AnaptysBio, Inc. (ANAB)
62.19
-0.50
(-0.79%)
USD |
NASDAQ |
May 14, 16:00
62.09
-0.10
(-0.16%)
After-Hours: 20:00
AnaptysBio Cash and Short Term Investments (Quarterly) : 286.46M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 202.31M |
| TG Therapeutics, Inc. | 514.43M |
| ADMA Biologics, Inc. | 138.15M |
| Mirum Pharmaceuticals, Inc. | 386.26M |
| Rigel Pharmaceuticals, Inc. | 146.68M |